The Federal Trade Commission cleared the New York investor to buy more shares in Biogen, the world's largest maker of drugs for multiple sclerosis, according to a message posted yesterday on the agency's Web site.
Sunday, August 26, 2007
Icahn May Boost Biogen Stake, Forecasts Takeover
Billionaire investor Carl C. Icahn may increase his stake in Biogen Idec Inc. because he says the company is undervalued and a takeover candidate, according to a person familiar with Icahn's thinking.
The Federal Trade Commission cleared the New York investor to buy more shares in Biogen, the world's largest maker of drugs for multiple sclerosis, according to a message posted yesterday on the agency's Web site.
Full Article
The Federal Trade Commission cleared the New York investor to buy more shares in Biogen, the world's largest maker of drugs for multiple sclerosis, according to a message posted yesterday on the agency's Web site.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment